AAD 2026 Highlights – Denver, USA: What’s New in Dermatology Treatments
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
At the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, major shifts in dermatology became clear — and they’re already starting to change how we treat patients.
In this episode of SkinScope, Dr Sandra Jerkovic Gulin and Dr George Kravvas break down the most important clinical updates in a clear, practical, and engaging way.
We go beyond the headlines to explore what these advances actually mean in real life — for dermatologists, residents, and patients.
💡 In this episode, we discuss:
- Why dermatology is shifting toward pathway-driven, precision medicine
- The expanding role of JAK inhibitors across multiple diseases
- New hope in alopecia areata — and why it’s more than “just hair loss”
- Breakthrough momentum in vitiligo, including systemic treatment potential
- Major progress in hidradenitis suppurativa and the move toward functional remission
- The rise of oral therapies competing with biologics in psoriasis
- Long-term disease control in atopic dermatitis, with less reliance on steroids
- New options for chronic urticaria beyond antihistamines
- The growing role of dermatologists as systemic disease specialists
🎧 About SkinScopeSkinScope is hosted by Dr Sandra Jerkovic Gulin and Dr George Kravvas, exploring skin health through science, evidence-based dermatology, and real-world clinical experience.
👩⚕️ Dr Sandra Jerkovic Gulin (Sweden)
📸 Instagram: https://www.instagram.com/skindoc_sandra_jg
👨⚕️ Dr George Kravvas (UK)
🌐 Website: https://drkravvasdermatology.co.uk
📸 Instagram: https://www.instagram.com/drgeorgekravvas
🎧 Listen now and discover news from AAD 2026 in Denver, USA